| |
| |
 |
| |
|
|
| |
Gynoflor® vaginal tablets contain more than 100
million viable Lactobacillus acidophilus (L. acidophilus)and 0.03 mg estriol.
|
|
| |
|
|
| |
Both active substances in Gynoflor® , estriol and L.
acidophilus, are physiologically present in the vagina .They play an important role in natural defence mechanisms against pathogenic mirco-organisms and are two of the major players in maintaining a healthy vaginal ecosystem. |
|
| |
|
|
| |
Gynoflor® is a unique product with a dual mechanism of action supporting the restoration of both the vaginal epithelium and microflora, and has been efficiently used where the establishment and maintenance of a healthy vaginal ecosystem is important:
| |
|
| • |
Restoration of vaginal flora after local and/or systemic treatment |
| |
with anti-microbial agents. |
| • |
Atrophic vaginitis due to estrogen deficiency during menopause |
| |
and postmenopause, or as co-medication to systemic hormone |
| |
replacement therapy. |
| • |
Prevention of vaginal infection recurrence and relapse |
|
|
| |
The dosage of Gynoflor® depends on the specific indication and seriousness of the disorder to be treated. A dose of 1 to 2 vaginal tablets per day over 6 to 12 days is usually recommended, which- if required- can be followed by a maintenance dose of 1 vaginal tablet on 1 to 2 days per week. |
|
| |
|
|
| |
For further information, please consult your doctor or call 2895 9490 for product information. |
|
| |
|
|
|
|
|
| |
 |
|
| |
Copyright © 2011 www.gynoflor.com.hk All rights reserved.
|
|
